ReviewFrontiers in neuroscience2026

GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.

Christian HölscherPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.